FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
View original at finance.yahoo.comFDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs Expanded label for once-yearly parasiticide treatment for dogs now includes Haemaphysalis longicornis (Asian longhorned tic…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Asian longhorned and Gulf Coast ticks continue to expand geographically and present risks to canine health
60% confidenceFor more than a decade, BRAVECTO has set the benchmark for extended-duration flea and tick protection
60% confidenceFleas are the most common external parasite found on pets
60% confidenceFleas and ticks are not only active in the spring and summer months and are a year-round risk
60% confidenceThe flea lifecycle can last as long as 12 weeks, and monthly treatments may leave gaps in protection
60% confidenceSafety was demonstrated when BRAVECTO QUANTUM was dosed at 5 times the recommended dose every 4 months for a total of 6 doses
60% confidenceBRAVECTO QUANTUM is the longest-lasting flea and tick protection available for dogs in the United States
60% confidenceBRAVECTO QUANTUM delivers the longest-lasting protection available in a single dose, now covering an even broader range of clinically important tick species
60% confidence